Upregulation of interleukin-33 in the epidermis of two Japanese patients with Netherton syndrome

Journal of Dermatology

Volumn 41, Issue 3, 2014, Pages 258-261

  Konishi, Tomoko ^a   Tsuda, Tatsuya ^a   Sakaguchi, Yoshiko ^a   Imai, Yasutomo ^a   Ito, Takashi ^a,b   Hirota, Seiichi ^a   Yamanishi, Kiyofumi ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b Department of Clinical Pathology Sanda City Hospital   (Japan)

Author keywords

atopic dermatitis; interleukin 33; mutation; Netherton syndrome; SPINK5

Indexed keywords

CASEIN; EOSIN; FAT DROPLET; FLUORESCEIN ISOTHIOCYANATE; HEMATOXYLIN; IMMUNOGLOBULIN E; INTERLEUKIN 33; INVOLUCRIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; TRANSGLUTAMINASE 1; UNCLASSIFIED DRUG; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; LEUKOCYTE ELASTASE INHIBITOR; SPINK5 PROTEIN, HUMAN;

ACANTHOSIS; ARTICLE; ATOPIC DERMATITIS; CASE REPORT; CELL INFILTRATION; CYANOSIS; DESQUAMATION; DYSPNEA; ELECTRON MICROSCOPY; ENZYME INDUCTION; ERYTHEMA; ERYTHRODERMA; FEMALE; GENE MUTATION; GROWTH RETARDATION; HUMAN; HYPERNATREMIA; IMMUNOFLUORESCENCE; INFANT; INFLAMMATORY CELL; INTERCELLULAR SPACE; JAPAN; JAPANESE; MECONIUM ASPIRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MILK ALLERGY; NETHERTON DISEASE; PARAKERATOSIS; PATHOPHYSIOLOGY; RADIOALLERGOSORBENT TEST; SCANTY HAIR; SEBORRHEIC DERMATITIS; SEPTICEMIA; SERRATIA MARCESCENS; SKIN DEFECT; STRATUM CORNEUM; STRIDOR; EPIDERMIS; GENETICS; METABOLISM; NEWBORN; PATHOLOGY; PREMATURITY; UPREGULATION;

EPIDERMIS; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INTERLEUKINS; NETHERTON SYNDROME; PROTEINASE INHIBITORY PROTEINS, SECRETORY; UP-REGULATION;

EID: 84896400639     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/1346-8138.12410     Document Type: Article

References (13)

1. Chavanas S, Bodemer C, Rochat A, et al,. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-142.
2. Descargues P, Deraison C, Bonnart C, et al,. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 2005; 37: 56-65.
3. Descargues P, Deraison C, Prost C, et al,. Corneodesmosomal cadherins are preferential targets of stratum corneum trypsin- and chymotrypsin-like hyperactivity in Netherton syndrome. J Invest Dermatol 2006; 126: 1622-1632.
4. Briot A, Deraison C, Lacroix M, et al,. Kallikrein 5 induces atopic dermatitis-like lesions through PAR2-mediated thymic stromal lymphopoietin expression in Netherton syndrome. J Exp Med 2009; 206: 1135-1147.
5. Briot A, Lacroix M, Robin A, Steinhoff M, Deraison C, Hovnanian A,. Par2 inactivation inhibits early production of TSLP, but not cutaneous inflammation, in Netherton syndrome adult mouse model. J Invest Dermatol 2010; 130: 2736-2742.
6. Nakae S, Morita H, Ohno T, Arae K, Matsumoto K, Saito H,. Role of interleukin-33 in innate-type immune cells in allergy. Allergol Int 2013; 62: 13-20.
7. Savinko T, Matikainen S, Saarialho-Kere U, et al,. IL-33 and ST2 in atopic dermatitis: expression profiles and modulation by triggering factors. J Invest Dermatol 2012; 132: 1392-1400.
8. Meephansan J, Tsuda H, Komine M, Tominaga S, Ohtsuki M,. Regulation of IL-33 expression by IFN-gamma and tumor necrosis factor-alpha in normal human epidermal keratinocytes. J Invest Dermatol 2012; 132: 2593-2600.
9. Meephansan J, Komine M, Tsuda H, Karakawa M, Tominaga S, Ohtsuki M,. Expression of IL-33 in the epidermis: the mechanism of induction by IL-17. J Dermatol Sci 2013; 71: 107-114.
10. Imai Y, Yasuda K, Sakaguchi Y, et al,. Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice. Proc Natl Acad Sci U S A 2013; 110: 13921-13926.
11. Fartasch M, Williams ML, Elias PM,. Altered lamellar body secretion and stratum corneum membrane structure in Netherton syndrome: differentiation from other infantile erythrodermas and pathogenic implications. Arch Dermatol 1999; 135: 823-832.
12. Hiiragi T, Sasaki H, Nagafuchi A, et al,. Transglutaminase type 1 and its cross-linking activity are concentrated at adherens junctions in simple epithelial cells. J Biol Chem 1999; 274: 34148-34154.
13. Raghunath M, Tontsidou L, Oji V, et al,. SPINK5 and Netherton syndrome: novel mutations, demonstration of missing LEKTI, and differential expression of transglutaminases. J Invest Dermatol 2004; 123: 474-483.